Stephen E. Straus
#138,262
Most Influential Person Now
Stephen E. Straus's AcademicInfluence.com Rankings
Stephen E. Strausphilosophy Degrees
Philosophy
#7088
World Rank
#10249
Historical Rank
Logic
#4164
World Rank
#5423
Historical Rank
Download Badge
Philosophy
Why Is Stephen E. Straus Influential?
(Suggest an Edit or Addition)Stephen E. Straus's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study (1994) (4599)
- A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. (2005) (1780)
- Chronic fatigue syndrome: a working case definition. (1988) (1721)
- Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome (1995) (1516)
- The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. (1994) (1377)
- Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. (1991) (738)
- Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency (2002) (712)
- Inherited Human Caspase 10 Mutations Underlie Defective Lymphocyte and Dendritic Cell Apoptosis in Autoimmune Lymphoproliferative Syndrome Type II (1999) (637)
- Postherpetic neuralgia--pathogenesis, treatment, and prevention. (1996) (603)
- Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. (1985) (531)
- The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. (2001) (452)
- Requirement for Caspase-8 in NF-κB Activation by Antigen Receptor (2005) (397)
- Epstein-Barr Virus Infections: Biology, Pathogenesis, and Management (1993) (394)
- Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. (1997) (380)
- NIH conference. Varicella-zoster virus infections. Biology, natural history, treatment, and prevention. (1988) (321)
- An Inherited Disorder of Lymphocyte Apoptosis: The Autoimmune Lymphoproliferative Syndrome (1999) (303)
- NIH conference. Chronic fatigue syndrome research. Definition and medical outcome assessment. (1992) (300)
- A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease. (1992) (300)
- Suppression of frequently recurring genital herpes. A placebo-controlled double-blind trial of oral acyclovir. (1984) (291)
- Psychiatric diagnoses in patients who have chronic fatigue syndrome. (1989) (261)
- Fulminant EBV+ T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome (2000) (238)
- Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease (1999) (235)
- Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. (2011) (233)
- NRAS mutation causes a human autoimmune lymphoproliferative syndrome (2007) (232)
- Requirement for caspase-8 in NF-kappaB activation by antigen receptor. (2005) (229)
- Research into complementary and alternative medicine: problems and potential (2001) (226)
- Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance. (1999) (215)
- Acyclovir treatment of the chronic fatigue syndrome. Lack of efficacy in a placebo-controlled trial. (1988) (211)
- Pathological findings in human autoimmune lymphoproliferative syndrome. (1998) (210)
- Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection. (1987) (208)
- HIV-1 Directly Kills CD4+ T Cells by a Fas-independent Mechanism (1998) (200)
- Dysautonomias: Clinical Disorders of the Autonomic Nervous System (2002) (191)
- Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia. (1999) (187)
- Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome. (2000) (184)
- The chronic mononucleosis syndrome. (1988) (183)
- Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: results of a placebo-controlled vaccine trial. (1997) (168)
- The Persian Gulf Experience and Health (1994) (157)
- Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial. (1998) (155)
- Brief report: recurrent acyclovir-resistant genital herpes in an immunocompetent patient. (1993) (152)
- SPOTS: signaling protein oligomeric transduction structures are early mediators of death receptor-induced apoptosis at the plasma membrane. (2004) (149)
- Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation. (2004) (142)
- Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome. (2001) (139)
- Ethical issues concerning research in complementary and alternative medicine. (2004) (137)
- Histologic Features of Sinus Histiocytosis With Massive Lymphadenopathy in Patients With Autoimmune Lymphoproliferative Syndrome (2005) (135)
- PROPAGATION AND IN VITRO STUDIES OF PREVIOUSLY NON-CULTIVABLE ENTERAL ADENOVIRUSES IN 293 CELLS (1981) (132)
- Analysis of neuropsychological functioning in patients with chronic fatigue syndrome. (1993) (131)
- Acyclovir for chronic mucocutaneous herpes simplex virus infection in immunosuppressed patients. (1982) (130)
- What is Chronic Fatigue Syndrome? Heterogeneity Within an International Multicentre Study (2001) (128)
- Allergy and the chronic fatigue syndrome. (1988) (128)
- Oral Acyclovir To Suppress Frequently Recurrent Herpes Labialis: A Double-Blind, Placebo-Controlled Trial (1993) (121)
- Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity. (1997) (121)
- The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis. (1998) (117)
- Reactivation of latent herpes simplex virus infection by ultraviolet light: a human model. (1987) (116)
- Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression. (2001) (115)
- Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis). (1985) (111)
- Randomized Controlled Trial of Adenine Arabinoside Monophosphate for Chronic Type B Hepatitis (1984) (110)
- History of chronic fatigue syndrome. (1991) (109)
- Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome (2005) (109)
- Autoimmune lymphoproliferative syndrome (2003) (104)
- Decreased postexercise facilitation of motor evoked potentials in patients with chronic fatigue syndrome or depression (1996) (102)
- Induction of apoptosis and activation of NF‐κB by CD95 require different signalling thresholds (2004) (101)
- Acquisition of genital herpes from an asymptomatic sexual partner. (1986) (101)
- Death in the AIDS patient: role of cytomegalovirus. (1983) (98)
- Herpes Simplex Virus Infection: Biology, Treatment, and Prevention (1985) (96)
- TcR-alpha/beta(+) CD4(-)CD8(-) T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesis. (2001) (95)
- Attention and short‐term memory in chronic fatigue syndrome patients (1992) (92)
- Epstein-Barr virus in the bone marrow of patients with aplastic anemia. (1988) (91)
- Herbal medicines--what's in the bottle? (2002) (88)
- Autoimmune lymphoproliferative syndrome. A human disorder of abnormal lymphocyte survival. (2000) (86)
- NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and management. (1993) (84)
- Oral acyclovir to suppress recurring herpes simplex virus infections in immunodeficient patients. (1984) (84)
- Chronic Epstein-Barr virus infection. (1987) (81)
- Implementing a research agenda for complementary and alternative medicine. (2004) (77)
- Detection of serum antibodies to a Kaposi's sarcoma-associated herpesvirus-specific peptide. (1997) (76)
- Causes and consequences of the autoimmune lymphoproliferative syndrome (2006) (73)
- Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib (2007) (73)
- Acute infectious mononucleosis. CD30 (Ki-1) antigen expression and histologic correlations. (1990) (73)
- Plasma and cerebrospinal fluid monoamine metabolism in patients with chronic fatigue syndrome: Preliminary findings (1992) (73)
- Circulating lymphokine levels in the chronic fatigue syndrome. (1989) (72)
- Treatment of chronic non‐A, non‐B hepatitis with acyclovir: Pilot study (1985) (71)
- Acyclovir suppression of frequently recurring genital herpes. Efficacy and diminishing need during successive years of treatment. (1988) (71)
- Complementary and alternative medicine: opportunities and challenges for cancer management and research. (2002) (69)
- A composite picture of TcRα/β+ CD4-CD8- T cells (α/β-DNTCs) in humans with autoimmune lymphoproliferative syndrome (2002) (67)
- Complementary and alternative medicine: assessing the evidence for immunological benefits (2004) (66)
- Acyclovir treatment of the chronic fatigue syndrome. (1988) (66)
- Protection from herpes simplex virus (HSV)-2 infection with replication-defective HSV-2 or glycoprotein D2 vaccines in HSV-1-seropositive and HSV-1-seronegative guinea pigs. (2009) (61)
- Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndrome (2006) (60)
- Chronic Epstein-Barr virus disease: a workshop held by the National Institute of Allergy and Infectious Diseases. (1985) (58)
- Histopathologic changes associated with fialuridine hepatotoxicity. (1997) (58)
- Business outlook: Development of therapeutics: opportunities within complementary and alternative medicine (2002) (53)
- Culture-proven cytomegalovirus retinitis in a homosexual man with the acquired immunodeficiency syndrome. (1982) (52)
- Clinical Management of Herpes Viruses (1995) (50)
- Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr(-/-) murine model of autoimmune lymphoproliferative syndrome (ALPS). (2009) (49)
- Complementary and alternative therapeutics: rigorous research is needed to support claims. (2003) (49)
- Decreased bone mineral density during low dose glucocorticoid administration in a randomized, placebo controlled trial. (2000) (49)
- Lymphocyte phenotype and function in the chronic fatigue syndrome (2004) (49)
- MIP-1alpha expression in tissues from patients with hemophagocytic syndrome. (1999) (49)
- A composite picture of TcR alpha/beta(+) CD4(-)CD8(-) T Cells (alpha/beta-DNTCs) in humans with autoimmune lymphoproliferative syndrome. (2002) (48)
- Kaposi's sarcoma (KS)-associated herpesvirus-like DNA sequences in peripheral blood mononuclear cells: association with KS and persistence in patients receiving anti-herpesvirus drugs. (1996) (48)
- Low‐Dose Hydrocortisone for Treatment of Chronic Fatigue Syndrome: A Randomized Controlled Trial (1999) (47)
- Alveolar bone necrosis and tooth loss. a rare complication associated with herpes zoster infection of the fifth cranial nerve. (1983) (47)
- Comparison of immunogenicity and protective efficacy of genital herpes vaccine candidates herpes simplex virus 2 dl5-29 and dl5-29-41L in mice and guinea pigs. (2008) (45)
- Complementary and Alternative Medicine (2006) (44)
- Neutrophil and platelet antibodies in autoimmune lymphoproliferative syndrome (2003) (43)
- Chronic Fatigue Syndrome and Herpesviruses: the Fading Evidence. (2000) (42)
- Chronic fatigue syndrome (1996) (39)
- Defining the chronic fatigue syndrome. (1992) (38)
- Herpesvirus vaccines. Development, controversies, and applications. (1999) (37)
- Clinical and biological differences between recurrent herpes simplex virus and varicella-zoster virus infections. (1989) (37)
- Antibodies to Epstein-Barr virus in iridocorneal endothelial syndrome. (1990) (37)
- Abnormalities in response to vasopressin infusion in chronic fatigue syndrome (2001) (37)
- Using an interleukin-6 challenge to evaluate neuropsychological performance in chronic fatigue syndrome (2002) (36)
- Complementary and alternative medicine: challenges and opportunities for American medicine. (2000) (36)
- Discrete alterations in the BZLF1 promoter in tumor and non-tumor-associated Epstein-Barr virus. (2003) (34)
- In utero diagnosis of congenital varicella zoster virus infection by chorionic villus sampling and polymerase chain reaction. (1991) (34)
- Intravenous immunoglobulin treatment for the chronic fatigue syndrome. (1990) (33)
- Kaposi's sarcoma (KS)-associated herpesvirus-like DNA sequences in peripheral blood mononuclear cells: association with KS and persistence in patients receiving anti-herpesvirus drugs (1996) (32)
- UV light-induced reactivation of herpes simplex virus type 2 and prevention by acyclovir. (1992) (31)
- Shingles. Sorrows, salves, and solutions. (1993) (31)
- Autoimmune lymphoproliferative syndrome: a syndrome associated with inherited genetic defects that impair lymphocytic apoptosis--CT and US features. (1999) (30)
- Successful treatment with acyclovir of an immunodeficient patient infected simultaneously with multiple herpesviruses. (1981) (29)
- Exploratory Analysis of the Relationships between Aerobic Capacity and Self‐Reported Fatigue in Patients with Rheumatoid Arthritis, Polymyositis, and Chronic Fatigue Syndrome (2009) (29)
- Combination Therapy with Famciclovir and Interferon-α for the Treatment of Chronic Hepatitis B (1998) (29)
- Acute progressive Epstein-Barr virus infections. (1992) (29)
- A genetic disorder of lymphocyte apoptosis involving the fas pathway: The autoimmune lymphoproliferative syndrome (2001) (28)
- Getting It Right: Being Smarter about Clinical Trials (2006) (28)
- Periodic illness associated with Epstein-Barr virus infection. (1996) (28)
- Chronic fatigue syndrome: point and counterpoint. (1994) (27)
- St. John's Wort: more implications for cancer patients. (2002) (27)
- Clinical Course and Histology (1988) (26)
- Eosinophilia is associated with a higher mortality rate among patients with autoimmune lymphoproliferative syndrome (2007) (26)
- Fluorodeoxyglucose positron emission tomography (FDG‐PET) for monitoring lymphadenopathy in the autoimmune lymphoproliferative syndrome (ALPS) (2006) (26)
- The Inoue-Melnick virus, human herpesvirus type 6, and the chronic fatigue syndrome. (1989) (25)
- Antiviral resistance in clinical practice. (1995) (25)
- EB or not EB--that is the question. (1987) (24)
- Somatic mutations--not just for cancer anymore. (2004) (24)
- RBC autoantibodies in autoimmune lymphoproliferative syndrome (2001) (24)
- Chronic fatigue syndrome: Lack Of association with hepatitis C virus infection (1991) (24)
- Lack of association between HSV-1 DNA in the brain, Alzheimer’s disease and apolipoprotein E4 (2001) (23)
- Double-blind comparison of weekend and daily regimens of oral acyclovir for suppression of recurrent genital herpes. (1986) (23)
- Pyrimethamine treatment does not ameliorate lymphoproliferation or autoimmune disease in MRL/lpr−/− mice or in patients with autoimmune lymphoproliferative syndrome (2007) (23)
- Immunoactive cannabinoids: therapeutic prospects for marijuana constituents. (2000) (22)
- SPOTS (2004) (22)
- Bridging the gulf in war syndromes (1999) (22)
- Self-reported sensitivity to chemical exposures in five clinical populations and healthy controls (2000) (21)
- Glucose and insulin variations in patients during the time course of a FDG-PET study and implications for the "glucose-corrected" SUV. (2008) (21)
- Herpes simplex type 2 infections--an update. (2000) (21)
- The number of herpes simplex virus-infected neurons and the number of viral genome copies per neuron correlate with the latent viral load in ganglia. (2008) (21)
- Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis. (1984) (20)
- Echovirus Meningomyeloencephalitis with Administration of Intrathecal Immunoglobulin (1985) (19)
- Varicella-Zoster Virus Infections (2020) (18)
- Chronic fatigue syndrome. (1995) (18)
- Infectious Mononucleosis Epidemiology and Pathogenesis (1989) (18)
- Caring for patients with chronic fatigue syndrome (2002) (18)
- Chronic fatigue syndrome. (1996) (17)
- Lack of seasonal variation of symptoms in patients with chronic fatigue syndrome (1998) (17)
- The Postviral Chronic Fatigue Syndrome: A Roundtable (1989) (17)
- Description of serologic features in autoimmune lymphoproliferative syndrome (2000) (17)
- Studies of herpesvirus infection in chronic fatigue syndrome. (2007) (17)
- Aberrant T-cell antigen receptor-mediated responses in autoimmune lymphoproliferative syndrome. (2002) (16)
- Bilateral uveitis in a patient with autoimmune lymphoproliferative syndrome. (2005) (15)
- Autoimmune lymphoproliferative syndrome: A cause of chronic splenomegaly, lymphadenopathy, and cytopenias in children—report on diagnosis and management of five patients (2004) (14)
- The Spectrum of Histoplasmosis in a General Hospital: A Review of 55 Cases Diagnosed at Barnes Hospital Between 1966 and 1977 (1980) (14)
- Immunostimulation by cytomegalovirus (CMV): helper T cell-dependent activation of immunoglobulin production in vitro by lymphocytes from CMV-immune donors. (1985) (14)
- The Post-Infectious Chronic Fatigue Syndrome (1989) (14)
- Chronic mononucleosis--a legitimate diagnosis. (1988) (14)
- Prophylactic and therapeutic effects of human immunoglobulin on the pathobiology of HSV-1 infection, latency, and reactivation in mice (2011) (13)
- Report of a factor VIII inhibitor in a patient with autoimmune lymphoproliferative syndrome (2000) (13)
- In Defense of NCCAM (2006) (12)
- The chronic fatigue syndrome: considerations relevant to children and adolescents. (1992) (12)
- The autoimmune lymphoproliferative syndrome (2001) (12)
- Zoster and its complications. (1990) (12)
- An erythrocyte Pr auto‐antibody with sialoglycoprotein specificity in a patient with purine nucleoside phosphorylase deficiency (1985) (12)
- Combination therapy with famciclovir and interferon-alpha for the treatment of chronic hepatitis B. (1998) (12)
- Lymphocyte analysis in a patient with X-linked agammaglobulinemia and isolated growth hormone deficiency after development of echovirus dermatomyositis and meningoencephalitis. (1989) (11)
- HLA B44 is associated with decreased severity of autoimmune lymphoproliferative syndrome in patients with CD95 defects (ALPS type Ia). (2006) (11)
- Complementary and alternative medicine: the convergence of public interest and science in the United States (2004) (11)
- Acyclovir Suppresses Subclinical Shedding of Herpes Simplex Virus (1996) (11)
- Electron microscopy for the diagnosis of ocular viral infections. (1981) (10)
- Suppression of recurrent genital herpes with oral acyclovir. (1983) (10)
- The Canale-Smith syndrome. (1997) (9)
- Postherpetic neuralgia. Predicting and preventing risk. (1997) (9)
- A cluster of cases of chronic fatigue and chronic fatigue syndrome: clinical and immunologic studies. (1996) (9)
- TORCH infections. Diagnosis in the molecular age. (1992) (8)
- Latency In Vitro of Varicella-Zoster Virus in Cells Derived from Human Fetal Dorsal Root Ganglia (1992) (8)
- Therapy for Varicelia-Zoster Virus Infections: Where Do We Stand? (1993) (8)
- Therapeutic immunization for recurrent herpes simplex virus infections. (1996) (8)
- Xenotropic murine leukemia virus-related virus is not associated with chronic fatigue syndrome in patients from different areas of the us in the 1990s (2011) (8)
- Vaccine Therapy for Herpes Simplex Virus Infections: An Historical Perspective (1996) (8)
- Treatment of mucocutaneous herpes simplex infections. (1984) (8)
- Phenelzine in the treatment of aphthous ulcers of the mouth. (1985) (7)
- Patients with chronic fatigue syndrome and accurate feeling-of-knowing judgments. (1997) (7)
- NIH Conference. Herpes simplex virus infection: biology, treatment, and prevention. (1985) (6)
- Interferon and 2-5A synthetase in patients with immune diseases. (1985) (5)
- Reevaluation of Diagnostic Histoplasma Serologies (1981) (5)
- POSTHERPETIC NEURALGIA : PREDICTING AND PREVENTING RISK (1997) (5)
- Pharmacotherapy of chronic fatigue syndrome: another gallant attempt. (2004) (5)
- A postviral chronic fatigue syndrome: a round table. (1989) (5)
- Science and government. Enhanced: in defense of NCCAM. (2006) (5)
- Advances in the treatment of chronic hepatitis B virus infection (1998) (5)
- Antifungal therapy for candidal meningitis. (1978) (4)
- Discrete Alterations in the BZLF 1 Promoter in Tumor and Non-Tumor-Associated Epstein-Barr Virus (2002) (4)
- Chapter 10 – Unanticipated Risk in Clinical Research (2012) (3)
- Significantly Elevated Vitamin B12 Levels in Autoimmune Lymphoproliferative Syndrome (ALPS), a Rare Lymphoproliferative Disorder with Apoptosis Defect (2008) (3)
- Drug Combinations for Treatment of Mice Infected with Acyclovir-Resistant Herpes Simplex Virus (3)
- Treatment of persistent active herpesvirus infections. (1988) (3)
- Relapsing, Recurrent, and Chronic Infectious Mononucleosis in the Normal Host (1985) (3)
- Chronic Fatigue Syndrome Research (2020) (3)
- Valproic Acid (VPA), a Histone Deacetylase (HDAC) Inhibitor, Diminishes Lymphoproliferation in the Fas Deficient MRL/lpr−/− Murine Model of Autoimmune Lymphoproliferative Syndrome (ALPS). (2006) (3)
- Psychopharmacology: an essential discipline for the critical investigation of complementary and alternative medicines. (2000) (3)
- Unanticipated Risk in Clinical Research (2007) (2)
- Prevention of nosocomial varicella zoster disease. (1981) (2)
- Serologic tests for histoplasmosis. (1983) (2)
- Herpes simplex type 2 infections--an update. (2000) (2)
- Response to: "Rescuing the NIH before it is too late". (2006) (2)
- Definition and Medical Outcome Assessment (2009) (2)
- The management of varicella and zoster infections. (1987) (2)
- Treatment of acyclovir (ACV)-resistant zoster with foscarnet in a man with AIDS (1991) (2)
- Gonococcal arthritis in the elderly. (1978) (1)
- Infectious complications of lung cancer (1983) (1)
- Varicella-zoster virus immunity and prevention: a conference perspective. (2001) (1)
- Role of Somatic Fas Mutations in the Pathogenesis of Autoimmune Lymphoproliferative Syndrome (ALPS). (2006) (1)
- Hydroxychloroquine Diminishes Lymphoproliferation in the Fas Deficient MRL/lpr−/− Murine Model of Autoimmune Lymphoproliferative Syndrome (ALPS). (2007) (1)
- Immune Assessment of Patients with Chronic Active EBV Infection (CAEBV) (1985) (1)
- Samuel L. Katz: pioneer in development of and international advocate for vaccines. (2002) (1)
- Autoimmune Lymphoproliferative Syndrome: An Inherited Disorder with a High Incidence of Autoimmune Cytopenias (2003) (1)
- Dual-time point positron emission tomography (PET) using [F-18]-fluorodeoxyglucose (FDG) in patients with autoimmune lymphoproliferative syndrome (ALPS) (2006) (1)
- ANALYSIS OF HUMAN HERPESVIRUS-8 INFECTION IN CHILDREN AND ADULTS BY MEASURING SERUM ANTIBODIES TO A PEPTIDE OF A MINOR CAPSID PROTEIN OR BY PCR: 74 (1997) (1)
- Defective FAS Mediated Apoptosis in a Human Autoimmune Lymphoproliferative Syndrome. • 46 (1996) (0)
- NCCAM: a new plan, new priorities, and an open invitation. (2004) (0)
- Herpesvirus Research: From the Bedside to the Bench and Back Again (2005) (0)
- THE 10 MOST COMMON QUESTIONS ABOUT ACYCLOVIR AND HERPES (1993) (0)
- Cutaneous viral infections. (1990) (0)
- Contents Vol. 30, 2003 (2003) (0)
- Workshop summary (0)
- Take One – Get Two: Automated Red Blood Cell Collection (2003) (0)
- Book Review Marginal to Mainstream: Alternative Medicine in America By Mary Ruggie. 232 pp. New York, Cambridge University Press, 2004. $65 (cloth); $22.99 (paper). 0-521-83429-5 (cloth); 0-521-54222-7 (paper). (2004) (0)
- Membrane-associated antigens of herpes simplex virus. Discussion (1991) (0)
- The Role of Complementary and Alternative Medicine: Accommodating Pluralism (review) (2003) (0)
- syndrome Immunophenotypic profiles in families with autoimmune lymphoproliferative (2013) (0)
- St. John's Wort Interferes with Irinotecan (2002) (0)
- Pyrimethamine Does Not Diminish Lymphoproliferation in MRL/lpr−/− Mice and Patients with Autoimmune Lymphoproliferative Syndrome (ALPS). (2005) (0)
- Acute Herpes Zoster: Sympathetic Nerve Block Unsupported by Prospective Trial-Reply (1993) (0)
- 74 AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME (ALPS): A DISORDER OF DEFECTIVE LYMPHOCYTE APOPTOSIS MARKED BY PREDOMINANT TH2 CYTOKINE RESPONSES AND ELEVATED CIRCULATING IL-10 LEVELS. (1996) (0)
- 79 Immune-mediated cholestasis and hypercholecterolèmia associated with autoimmune lymphoproliferative syndrome (ALPS) (2000) (0)
- Summary of panel discussion about antiviral therapy for zoster (1996) (0)
- AN INCREASED RISK OF B-CELL LYMPHOMAS IN AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME (ALPS) (1999) (0)
- Dancing with a Dream: The Folly of Pursuing Alternative Medicine (2001) (0)
- Fatigue Syndrome-Reply (1988) (0)
- ODS-Sponsored Conference on Vitamin D to be Held September 5-6 at NIH (2007) (0)
- Whole-Body Positron Emission Tomography (PET) Using 2-18Fluoro-2-Deoxy-D-Glucose (FDG) for Monitoring Lymphadenopathy in Autoimmune Lymphoproliferative Syndrome (ALPS). (2004) (0)
- Concerning ‘Hepatitis C Virus’ (Transfus Med Hemother2003;30:239–250) (2003) (0)
- Pharmacotherapy of Chronic Fatigue Syndrome (2016) (0)
- Streptococcal pneumoniae sepsis in splenectomized patients with Autoimmune Lymphoproliferative Syndrome (ALPS) (2005) (0)
- Does idoxuridine help herpes labialis? (1985) (0)
- Table 69.3, Levels of Evidence for the Efficacy of Selected CAM and TM Approaches (2006) (0)
- The Natural History and Treatment of EBV Infections and Their Nonmalignant Complications (1989) (0)
- Subject Index Vol. 30, 2003 (2003) (0)
- Chapter 8 – Unanticipated Risk in Clinical Research (2002) (0)
- Management of Mucocutaneous Herpes Simplex Virus Infections (1984) (0)
- Erratum: Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia (Proceedings of the National Academy of Sciences of the United States of America (April 13, 1999) 96, 8 (4552-4557)) (2004) (0)
- THERAPEUTICS: Rigorous Research is Needed to Support Claims 1 (2003) (0)
- Genital Herpes: New treatment Strategies (1984) (0)
- Chapter 11 – Unanticipated Risk in Clinical Research∗ (2018) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Stephen E. Straus?
Stephen E. Straus is affiliated with the following schools:
